Spectrum Pharmaceuticals' P2P Acquisition

Spectrum Pharmaceuticals raised a round of funding on June 24, 2017. Investors include Repligen.

Spectrum Pharmaceuticals is a biotechnology company that brings pharmaceutical products to patients for unmet medical needs.…

Articles about Spectrum Pharmaceuticals' P2P Acquisition: